Skip to main content
. 2026 Jan 5;12:1671237. doi: 10.3389/fmed.2025.1671237

Table 2.

Identification of factors associated with sarcopenia in the patients on hemodialysis.

Variables Adjusted model 1 Adjusted model 2
Odds ratio
(95% CI)
p-value Odds ratio
(95% CI)
p-value
Older age (≥ 60 years) 3.14 (1.98–4.98) <0.001 3.03 (1.90–4.82) <0.001
Male sex 1.70 (1.09–2.65) 0.019 1.77 (1.13–2.78) 0.013
White ethnicity 2.02 (1.33–3.08) 0.001 1.92 (1.26–2.94) 0.003
Diabetes as CKD etiology or comorbidity 1.96 (1.29–2.98) 0.002 1.78 (1.16–2.73) 0.008
Body mass index
Normal weight Reference
Underweight 4.38 (0.67–28.55) 0.122 3.99 (0.57–28.01) 0.164
Overweight 0.36 (0.23–0.57) <0.001 0.37 (0.23–0.59) <0.001
Obesity 0.10 (0.04–0.25) <0.001 0.11 (0.05–0.26) <0.001
Hemodiafiltration
(reference = conventional)
1.45 (0.95–2.21) 0.085
Catheter access
(reference = arteriovenous fistula)
1.48 (0.95–2.30) 0.084
Physically active 0.54 (0.31–0.94) 0.028 0.59 (0.33–1.04) 0.066

CKD, chronic kidney disease; CI, confidence interval. Confirmed and severe sarcopenia groups were combined and classified as ‘sarcopenia’ for analysis. Adjusted model 1 included age (reference = <60 years), ethnicity (reference = non-white), sex (reference = female), diabetes as etiology or comorbidity (reference = no diabetes), body mass index (reference = normal weight), and physically active (reference = <150 min/week). Adjusted model 2 included all variables from model 1, with the addition of dialysis modality (reference = conventional) and vascular access (reference = arteriovenous fistula or graft).